https://wikifarmaco.org/index.php?action=history&feed=atom&title=Pegfilgrastim 2026-04-11T23:31:52Z Cronologia della pagina su questo sito MediaWiki 1.30.2 https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=51557&oldid=prev 2014-08-26T19:53:02Z

<p>Sostituzione testo - &#039;|titlemode= append&#039; con &#039;|titlemode=&#039;</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 19:53, 26 ago 2014</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}{{#seo:</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}{{#seo:</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|titlemode= <del class="diffchange diffchange-inline">append</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|titlemode=</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|keywords= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|keywords= &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|description= &#160;</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:45508:newid:51557 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=45508&oldid=prev 2014-03-21T13:41:31Z

<p>Sostituzione testo - &#039;{{Avvertenze}} {{#seo:&#039; con &#039;{{Avvertenze}}{{#seo:&#039;</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 13:41, 21 mar 2014</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>{{Avvertenze}}{{#seo:</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>{{#seo:</div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|title= &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|titlemode= append</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>|titlemode= append</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:38786:newid:45508 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=38786&oldid=prev 2013-12-20T00:29:47Z

<p>‎<span dir="auto"><span class="autocomment">SPECIALITÀ</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 00:29, 20 dic 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l8" >Riga 8:</td> <td colspan="2" class="diff-lineno">Riga 8:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Immunostimolanti|mode=all|onlyroot= |depth=}}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Immunostimolanti|mode=all|onlyroot= |depth=}}</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' 6MG 1SIR 0,6ML SC [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=<del class="diffchange diffchange-inline">2011</del>-<del class="diffchange diffchange-inline">10</del>-002464-Neulasta<del class="diffchange diffchange-inline">%20sir</del>.pdf''monografia'']</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' 6MG 1SIR 0,6ML SC [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=<ins class="diffchange diffchange-inline">2013</ins>-<ins class="diffchange diffchange-inline">11</ins>-002464-Neulasta.pdf''monografia'']</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:35820:newid:38786 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=35820&oldid=prev 2013-11-16T00:35:41Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 00:35, 16 nov 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{Avvertenze}}</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{#seo:</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|title= </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|titlemode= append</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|keywords= </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">|description= </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">}}</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Immunostimolanti|mode=all|onlyroot= |depth=}}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>{{categorytreeall|Immunostimolanti|mode=all|onlyroot= |depth=}}</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:30675:newid:35820 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=30675&oldid=prev 2013-04-27T21:35:15Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 21:35, 27 apr 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">&lt;categorytree </del>mode=all <del class="diffchange diffchange-inline">style</del>=<del class="diffchange diffchange-inline">&quot;float:right; clear:right; margin-left:1ex; border:1px solid gray; padding:0.7ex; background-color:skyblue;&quot;&gt;Immunostimolanti&lt;/categorytree&gt;</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">{{categorytreeall|Immunostimolanti|</ins>mode=all<ins class="diffchange diffchange-inline">|onlyroot</ins>= <ins class="diffchange diffchange-inline">|depth=}}</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' 6MG 1SIR 0,6ML SC [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-10-002464-Neulasta%20sir.pdf''monografia'']</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' 6MG 1SIR 0,6ML SC [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-10-002464-Neulasta%20sir.pdf''monografia'']</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:29434:newid:30675 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=29434&oldid=prev 2013-03-22T02:22:48Z

<p>‎<span dir="auto"><span class="autocomment">SPECIALITÀ</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 02:22, 22 mar 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>&lt;categorytree mode=all style=&quot;float:right; clear:right; margin-left:1ex; border:1px solid gray; padding:0.7ex; background-color:skyblue;&quot;&gt;Immunostimolanti&lt;/categorytree&gt;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>&lt;categorytree mode=all style=&quot;float:right; clear:right; margin-left:1ex; border:1px solid gray; padding:0.7ex; background-color:skyblue;&quot;&gt;Immunostimolanti&lt;/categorytree&gt;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' 6MG 1SIR 0,6ML SC <del class="diffchange diffchange-inline">[</del>[http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-10-002464-Neulasta%20sir.pdf''monografia'']</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' 6MG 1SIR 0,6ML SC [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-10-002464-Neulasta%20sir.pdf''monografia'']</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:29433:newid:29434 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=29433&oldid=prev 2013-03-22T02:22:37Z

<p>‎<span dir="auto"><span class="autocomment">SPECIALITÀ</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 02:22, 22 mar 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>&lt;categorytree mode=all style=&quot;float:right; clear:right; margin-left:1ex; border:1px solid gray; padding:0.7ex; background-color:skyblue;&quot;&gt;Immunostimolanti&lt;/categorytree&gt;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>&lt;categorytree mode=all style=&quot;float:right; clear:right; margin-left:1ex; border:1px solid gray; padding:0.7ex; background-color:skyblue;&quot;&gt;Immunostimolanti&lt;/categorytree&gt;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''monografia''] <del class="diffchange diffchange-inline">6MG 1SIR 0,6ML SC</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' <ins class="diffchange diffchange-inline">6MG 1SIR 0,6ML SC [</ins>[http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940<ins class="diffchange diffchange-inline">.pdf''Riassunto EMA''], [http://www.dottnet.it/TFI/Allegati.aspx?file=2011-10-002464-Neulasta%20sir</ins>.pdf''monografia'']</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:24604:newid:29433 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=24604&oldid=prev 2012-12-21T02:38:16Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 02:38, 21 dic 2012</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Riga 1:</td> <td colspan="2" class="diff-lineno">Riga 1:</td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;categorytree mode=all style=&quot;float:right; clear:right; margin-left:1ex; border:1px solid gray; padding:0.7ex; background-color:skyblue;&quot;&gt;Immunostimolanti&lt;/categorytree&gt;</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== SPECIALITÀ ==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''monografia''] 6MG 1SIR 0,6ML SC</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>*'''[[Neulasta]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000420/WC500025940.pdf''monografia''] 6MG 1SIR 0,6ML SC</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:15169:newid:24604 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=15169&oldid=prev 2012-05-27T21:28:40Z

<p>‎<span dir="auto"><span class="autocomment">MECCANISMO D’AZIONE</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 21:28, 27 mag 2012</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >Riga 5:</td> <td colspan="2" class="diff-lineno">Riga 5:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>Il '''pegfilgrastim''' è la forma pegilata di [[Filgrastim]] ottenuto coniugando covalentemente il filgrastim e una molecola di polietilenglicole&#160; (PEG). La pegilazione ne ritarda la clearance renale e ne prolunga l’emivita da 3,5 h per il [[filgrastim]] a 15-80 h per il '''pegfilgrastim'''.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>Il '''pegfilgrastim''' è la forma pegilata di [[Filgrastim]] ottenuto coniugando covalentemente il filgrastim e una molecola di polietilenglicole&#160; (PEG). La pegilazione ne ritarda la clearance renale e ne prolunga l’emivita da 3,5 h per il [[filgrastim]] a 15-80 h per il '''pegfilgrastim'''.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>il '''[[Filgrastim ]]''' è la forma ricombinante del fattore umano stimolante le colonie di granulociti (rHuG-CSF recombinant human G-CSF), una glicoproteina che regola la produzione e il rilascio di neutrofili dal midollo osseo.</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>il '''[[Filgrastim ]]''' è la forma ricombinante<ins class="diffchange diffchange-inline">, </ins>del fattore umano stimolante le colonie di granulociti (rHuG-CSF recombinant human G-CSF), una glicoproteina che regola la produzione e il rilascio di neutrofili dal midollo osseo<ins class="diffchange diffchange-inline">. </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Il '''Filgrastim''' viene prodotto utilizzando un ceppo del batterio Escherichia coli manipolato geneticamente mediante aggiunta del gene per il fattore di stimolazione delle colonie granulocitarie</ins>.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>I '''neutrofili''' sono un tipo di globuli bianchi presente nel sangue e servono a combattere le infezioni.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>I '''neutrofili''' sono un tipo di globuli bianchi presente nel sangue e servono a combattere le infezioni.</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:15168:newid:15169 --> </table>

Hadihajar https://wikifarmaco.org/index.php?title=Pegfilgrastim&diff=15168&oldid=prev 2012-05-27T21:12:02Z

<p>‎<span dir="auto"><span class="autocomment">MECCANISMO D’AZIONE</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="it"> <td colspan="2" style="background-color: white; color:black; text-align: center;">← Versione meno recente</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">Versione delle 21:12, 27 mag 2012</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l3" >Riga 3:</td> <td colspan="2" class="diff-lineno">Riga 3:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>== MECCANISMO D’AZIONE==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Il '''pegfilgrastim''' è la forma pegilata di [[Filgrastim]] ottenuto coniugando covalentemente il filgrastim e una molecola di polietilenglicole&#160; (PEG). La pegilazione ne ritarda la clearance <del class="diffchange diffchange-inline">plasmatica </del>e ne prolunga l’emivita da 3,5 h per il [[filgrastim]] a 15-80 h per il pegfilgrastim.</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Il '''pegfilgrastim''' è la forma pegilata di [[Filgrastim]] ottenuto coniugando covalentemente il filgrastim e una molecola di polietilenglicole&#160; (PEG). La pegilazione ne ritarda la clearance <ins class="diffchange diffchange-inline">renale </ins>e ne prolunga l’emivita da 3,5 h per il [[filgrastim]] a 15-80 h per il <ins class="diffchange diffchange-inline">'''</ins>pegfilgrastim<ins class="diffchange diffchange-inline">'''</ins>.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>il '''[[Filgrastim ]]''' è la forma ricombinante del fattore umano stimolante le colonie di granulociti (rHuG-CSF recombinant human G-CSF), una glicoproteina che regola la produzione e il rilascio di neutrofili dal midollo osseo.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>il '''[[Filgrastim ]]''' è la forma ricombinante del fattore umano stimolante le colonie di granulociti (rHuG-CSF recombinant human G-CSF), una glicoproteina che regola la produzione e il rilascio di neutrofili dal midollo osseo.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>I '''neutrofili''' sono un tipo di globuli bianchi presente nel sangue e servono a <del class="diffchange diffchange-inline">combatte </del>le infezioni.</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>I '''neutrofili''' sono un tipo di globuli bianchi presente nel sangue e servono a <ins class="diffchange diffchange-inline">combattere </ins>le infezioni.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>'''Il Pegfilgrastim induce quindi un aumento marcato del numero dei neutrofili nel sangue''' periferico entro 24 ore e il suo uso in pazienti sottoposti a trapianti di midollo osseo o trattati con chemioterapie citotossiche porta ad una significativa riduzione della durata della neutropenia e delle complicanze associate.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>'''Il Pegfilgrastim induce quindi un aumento marcato del numero dei neutrofili nel sangue''' periferico entro 24 ore e il suo uso in pazienti sottoposti a trapianti di midollo osseo o trattati con chemioterapie citotossiche porta ad una significativa riduzione della durata della neutropenia e delle complicanze associate.</div></td></tr> <!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:15167:newid:15168 --> </table>

Hadihajar